PPAR Research (ISSN 1687-4757) is an international, open-access journal published by Hindawi in the United States, dedicated exclusively to the study of peroxisome proliferator-activated receptors (PPARs). The journal encompasses a broad spectrum of research, ranging from the molecular mechanisms and pharmacological actions of PPARs to their clinical applications in metabolic disorders, inflammatory conditions, and oncology, thereby bridging the gap between basic science and translational medicine. While PPAR Research has historically been indexed in the Science Citation Index (SCI), prospective authors are advised to verify its current indexing status and impact factor, as these metrics can fluctuate. Additionally, given the evolving academic landscape and the need to assess the journal’s standing within the Chinese Academy of Sciences (CAS) journal ranking system, researchers should consult the latest annual partition tables to ensure alignment with their institutional requirements. Although the open-access model facilitates wide dissemination and may result in a higher volume of submissions, it is crucial to carefully evaluate the journal’s peer-review rigor and academic reputation, particularly in light of broader discussions regarding the publisher’s practices, to ensure that the work meets the highest standards of scientific integrity.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com